Programme members

Principal investigators and consultants

  • All members
  • Group leaders
  • Clinical consultants
University of Cambridge
Department of Chemistry
Fragment based drug discovery Mechanistic enzymology research on reactions in microdroplets in microfluidics, with potential applications...
PI:
Y
CC:
N
University of Cambridge
Department of Oncology
CRUK Cambridge Institute
Cancer Molecular Diagnostics Laboratory
PI:
N
CC:
N
Microsoft Research
Multi-omics metabolic models Optimization
PI:
N
CC:
N
University of Cambridge
Department of Chemistry
My group's research interests lies under the broader field of Chemical Biology. In particular, we are developing novel site-specific and...
PI:
Y
CC:
N
University of Cambridge
Core Pharmacokinetics/Bioanalytics
Development and validation of quantitative LC-MS/MS methods for the analysis small molecules and  metabolites/biomarkers in biological...
PI:
N
CC:
University of Cambridge
Department of Chemistry
The aim of my research is to build ruthenium organometallic groups into validated, medicinal compounds such that the ligand efficiency of...
PI:
Y
CC:
N
European Bioinformatics Institute
Functional genomics research
High throughput (microarray, sequencing) data analysis. Data integration. Cell cycle. I am in charge of running and developing the...
PI:
Y
CC:
N
CRUK Therapeutic Discovery Laboratories
Drug discovery at CRT working in medicinal chemistry to deliver small molecule inhibitors of cancer targets.
PI:
N
CC:
N
AstraZeneca
PI:
N
CC:
N
University of Cambridge
Department of Materials Science and Metallurgy
My research concerns medical materials. We design, produce and characterise materials designed for use within the body, materials for...
PI:
Y
CC:
N
AstraZeneca
Translational Science - Oncology Innovative Medicines Unit
Applying cutting edge genomic techniques to measure biomarkers and further understanding of response and resistance across a range of drug...
PI:
Y
CC:
N
AstraZeneca
Oncology
Oncology Biologics drug discovery
PI:
Y
CC:
N
Kathryn Chapman is the Deputy Director of the Milner Therapeutics Institute, a dynamic partnership between pharmaceutical companies and...
PI:
N
CC:
N
ImBio
ImBio
Developing cancer therapy as opposed to research. Autologous tumour-dendritic cell fusion hybrids for cancer therapy
PI:
Y
CC:
N
AstraZeneca, MedImmune
CRUK Cambridge Institute
AstraZeneca Oncology
Oncology
PI:
N
CC:
N
AstraZeneca
Cancer, DNA Damage, signaling network, mathematics and synergy: what is the connection? Paradoxically, defective cell response to DNA...
PI:
N
CC:
N
CRUK Therapeutic Discovery Laboratories
PI:
N
CC:
N
University of Cambridge
Department of Physics
My research is concerned with biophysical principles underlying protein aggregation and cell-substrate interactions, with a very strong...
PI:
Y
CC:
University of Cambridge
Department of Biochemistry
Current research aims to generate and functionally validate recombinant antibodies to cell surface receptors, growth factors or signalling...
PI:
N
CC:
University of Cambridge
Department of Pathology
Cancer genetics: application in prognosis and treatment stratification
PI:
N
CC:
N
AstraZeneca
UK trained Clinical Oncologist PhD in Oncology - Vascular Targeting Agents - endothelial cell shape change effects and translational...
PI:
Y
CC:
N
University of Cambridge
Department of Engineering
Main area systems Biology which includes modelling, analysis, and control of biochemical systems. My research is focus on two aspects: 1)...
PI:
Y
CC:
MedImmune
Oncology
Cancer Immunotherapy- In vitro profiling of immunostimulatory antibodies as well as elucidation of antibody efficacy and target rationale
PI:
N
CC:
University of Cambridge
Department of Physics
Wellcome Trust CRUK Gurdon Institute, Wellcome Trust MRC Cambridge Stem Cell Institute
Initially trained as a physicist and a chemist at the Ecole Normale Supérieure (Paris, France), I developed my interest for quantitative...
PI:
N
CC:
Other
Cancer Research UK Therapeutic Discovery Laboratories
Deputy Director of Discovery, Cancer Research UKTherapeutic Discovery Laboratories
PI:
Y
CC:
N
University of Cambridge
Milner Therapeutics Institute
My role is to lead the computational biology group at the Milner Therapeutics Institute University of Cambridge. I have responsibility to...
PI:
N
CC:
N
AstraZeneca
Director, translational science "
Head of department for UK translational science, oncology, AstraZeneca
PI:
N
CC:
N
Rebecca Harris is the Drug Discovery Programme Manager at the Milner Therapeutics Institute, and in this role has responsibilities as...
PI:
N
CC:
N
Wellcome Trust Sanger Institute
Development of new algorithms and computational tools for the analysis of large-scale cancer pharmacogenomics and functional genomics...
PI:
N
CC:
N
CRUK Therapeutic Discovery Laboratories
Department of Engineering
Discovery Bioscience
I am a senior group leader at Cancer Research Technology Discovery Laboratories [CRTDL] (a wholly owned subsidiary of Cancer Research UK)....
PI:
N
CC:
N
AstraZeneca
Astrazeneca
Developing novel therapeutics to treat cancer
PI:
N
CC:
University of Cambridge
Department of Engineering
My main research activities focus on the mechanical properties of soft disordered materials, including foams, granular materials, as well...
PI:
Y
CC:
Genestack Limited
Genestack Limited
Genestack was launched in 2012 with a mission to transform genomics big data computing and application engineering. We were founded by...
PI:
N
CC:
CRUK Therapeutic Discovery Laboratories
The application of Medicinal Chemistry to the design and development of anti-cancer agents.
PI:
N
CC:
University of Cambridge
Wellcome Trust CRUK Gurdon Institute
Tony Kouzarides is Professor of Cancer Biology at the University of Cambridge, Deputy Director of the Gurdon Institute and Director of the...
PI:
Y
CC:
N
University of Cambridge
Department of Chemistry
PI:
Y
CC:
University of Cambridge
Department of Chemistry
Centre for Applied Medical Statistics
later on
PI:
N
CC:
University of Cambridge
I am interested in developing and testing methodologies for modeling biomolecular process (also using bioinformatics and system biology); I...
PI:
Y
CC:
University of Cambridge
Department of Medical Genetics, Department of Materials Science and Metallurgy
My work involves designing electrochemical platform for the Molecularly Engineered Amperometric Recognition Scaffold (MEARS) in bio-sensing...
PI:
N
CC:
University of Cambridge
Department of Medicine
Cambridge Institute for Medical Research
My long standing research interest has involved understanding the genetic basis of susceptibility to autoimmune disease. More recently I...
PI:
N
CC:
MRC Laboratory of Molecular Biology
I have expertise in a wide range of biophysical techniques to characterise protein-protein and protein-ligand interactions to understand...
PI:
N
CC:
CRUK Therapeutic Discovery Laboratories
Molecular Pharmacology
CRT Discovery Laboratories bridges the gap between academia and industrial drug discovery and development, aiming to validate, de-risk and...
PI:
N
CC:
University of Cambridge
Department of Clinical Neuroscience
1: Application of nanotherapy to target endogenous neural stem cells in vivo for treatment of neurodegenerative diseases. 2: Application of...
PI:
Y
CC:
Sareum Ltd
Sareum Ltd
Sareum is a drug discovery and development company delivering targeted small molecule therapeutics, primarily focusing on cancer. Sareum...
PI:
Y
CC:
European Bioinformatics Institute, Wellcome Trust Sanger Institute, University of Cambridge
Department of Computer Laboratory
Bioinformatics Research fellow, Garvan Institute of Medical Research
.
PI:
N
CC:
University of Cambridge
Department of Oncology
CRUK Cambridge Institute
The Murphy Group studied cell surface proteinases that modulate both the extracellular matrix and the activities of key cytokines and...
PI:
Y
CC:
N
University of Cambridge
Department of Chemistry
University of Cambridge
Involved in the chemical synthesis of novel agents.
PI:
Y
CC:
Cambridge University Hospitals NHS Foundation Trust
Department of Oncology
1. screening studies (3) for BRCA1...
PI:
N
CC:
University of Cambridge
Computer Laboratory
I am a Mathematician and I am doing a PhD in bioinformatics at the University if Cambridge. I am currently working on gene network...
PI:
N
CC:
N
Other
Not applicable/other
PI:
N
CC:
University of Cambridge
Department of Physics
I work on radiotherapy projects with the Department of Oncology, making use of the computing expertise from my High Energy Physics research...
PI:
Y
CC:
University of Cambridge
Department of Chemistry
Organic synthesis - generally related to anticancer natural products and analogues. Synthesis of potent cytotoxic payloads for antibody-...
PI:
Y
CC:
University of Cambridge
MRC Cancer Unit
Hutchison MRC Research Centre
Studying the he cross-talk between tumour and its stromal microenvironment in order to choose the best targeting strategy to promote tumour...
PI:
N
CC:
N
DNA damage and repair, oncology clinical biomarkers
PI:
N
CC:
N
MISSION Therapeutics Ltd
Biology
Discovery and development of novel oncology drugs by inhibiting deubiquitylating enzymes within the DNA damage response, expoliting the...
PI:
N
CC:
Other
Kymab Ltd
I have 20 years of oncology research experience acquired both in academia (UC Irvine, USA and University of Oxford, UK) and industry (Kymab...
PI:
N
CC:
N
University of Cambridge
Not applicable/other
Wellcome Trust CRUK Gurdon Institute
PI:
N
CC:
N
University of Cambridge
Department of Physics
I'm programme co-ordinator for www.voxtox.org and www.accel-rt.org, two interdisciplinary computational radiotherapy research programmes.
PI:
N
CC:
University of Cambridge
Department of Chemistry
Our research interests are centered on using organic synthesis to make small molecules and peptides, which potentially could be used for...
PI:
Y
CC:
University of Cambridge
Department of Engineering
I am interested in developing engineering materials models for soft tissue in collaboration with medical researchers and clinicians and...
PI:
Y
CC:
CRUK Therapeutic Discovery Laboratories Cambridge
Cancer Research UK's Therapeutic Discovery Laboratories (CRUK-TDL), formerly CRT Discovery Laboratories, is the in-house CRUK drug...
PI:
N
CC:
N
University of Cambridge
Department of Biochemistry
My research as part of the Owen-Mott lab is in designing a small peptide therapeutic for Ras driven cancers. Abberant Ras signalling in...
PI:
N
CC:
N
University of Cambridge
Department of Biochemistry
Binding of antibiotics and drugs to DNA.   Development of new anti-cancer drugs.
PI:
Y
CC:
University of Cambridge
Department of Medicine
Cambridge Institute for Medical Research
I am interested in determining how human cytomegalovirus and other intracellular pathogens evade innate immunity. We recently developed ?...
PI:
N
CC:
Y
Wellcome Trust Sanger Institute
Cambridge Cancer Centre Executive Committee, Associate Director for Genetics and Genomics
PI:
N
CC:
N
University of Cambridge
Department of Applied Mathematics and Theoretical Physics
Cambridge Computational Biology Institute (CCBI)
Computational and Systems Approaches to Gene Circuits and Networks Controlling Chromosome Segregation and Morphogenesis; Gene Expression...
PI:
N
CC: